- 1 ODS individual review of accomplishments and goals
In preparation for the development of the strategic plan, ODS reviewed past and current progress and accomplishments as well as future goals for 2025–2029.
- 2 ODS office mission, vision, and priorities development
Priority setting for this strategic plan began with a reexamination of expert feedback on an interim plan developed for 2022–2026 to identify innovative ideas for ODS direction and ODS organizational structure. A small group of ODS staff used an iterative process to consider key questions about dietary supplement science (as described above) and delineate areas of scientific emphasis and opportunity. This process established strategic priorities and research objectives to advance biomedical research on dietary supplements. ODS staff also identified core research capacity and stewardship objectives.
- 3 Expert feedback
ODS is committed to engaging leaders across NIH Institutes, Centers, and Offices (ICOs) and representatives of the scientific community, industry, and other federal agencies in the strategic planning process. ODS gathered feedback from the Dietary Supplement Research Coordinating Committee (DSRCC) and ODS-partner review groups (NIH, federal, and external partners) on the goals, objectives, and strategic priorities that shape the 2025–2029 strategic plan.
- 4 Refinement of strategic plan
Reviewer feedback stimulated discussion among ODS staff regarding potential changes to include in the next version of the strategic plan.
- 5 Council of Councils review and feedback
A revised version of the plan was presented to the NIH Division of Program Coordination, Planning, and Strategic Initiatives Council of Councils and feedback was incorporated.
- 6 Public Comment
Known interested parties and the public were alerted to the availability of the strategic plan for comment through a Federal Register notice. ODS publicized the notice through its listserv, a notice on its website, and direct email with colleagues and other contacts. All feedback gathered was used to revise the ODS 2025–2029 strategic plan.
- 7 Finalized Strategic Plan
ODS shared a final version of the plan with NIH leadership for their approval and release to the public.